Management of Lithium-Associated Hypercalcemia with Elevated PTH

Diagnostic Evaluation

The American College of Physicians recommends measuring 25-hydroxyvitamin D levels to exclude vitamin D deficiency as a contributor to elevated PTH, as deficiency causes secondary hyperparathyroidism and must be corrected before making definitive management decisions 1
Assessing kidney function (eGFR) is important for determining monitoring frequency and treatment options, as recommended by the National Kidney Foundation 1

If lithium can be discontinued, the Endocrine Society recommends stopping lithium therapy and monitoring calcium and PTH levels every 2-4 weeks, as hypercalcemia and hyperparathyroidism may normalize within weeks to months in some patients 1
If hypercalcemia persists, the American Association of Clinical Endocrinologists recommends considering parathyroidectomy if calcium remains >12 mg/dL despite medical therapy, or if PTH exceeds 800 pg/mL with persistent hypercalcemia refractory to medical therapy 1
If lithium must be continued, the National Institute of Mental Health recommends initiating cinacalcet hydrochloride 30 mg daily as first-line medical therapy, and monitoring serum calcium monthly for 3 months, then every 3 months 1

The American College of Physicians recommends discontinuing all calcium supplements and vitamin D supplementation immediately, as these worsen hypercalcemia 3
Ensuring adequate oral hydration is crucial to promote calciuresis, as recommended by the European Renal Association 2
Reviewing and discontinuing thiazide diuretics if present is necessary, as these reduce urinary calcium excretion, according to the American Heart Association 2

During initial evaluation, the National Kidney Foundation recommends checking calcium and PTH every 2-4 weeks until stable 3
After treatment initiation, the Endocrine Society recommends monitoring calcium monthly for 3 months, then every 3 months 1
If on cinacalcet, the American Association of Clinical Endocrinologists recommends monitoring for hypocalcemia and assessing QT interval, as cinacalcet can prolong QT and is contraindicated in hypocalcemia 4

The American College of Physicians recommends not delaying surgical referral in patients with persistent hypercalcemia >12 mg/dL, as this can lead to progressive renal damage, nephrocalcinosis, and bone disease 1
The National Institute of Diabetes and Digestive and Kidney Diseases recommends not ordering parathyroid imaging before confirming biochemical diagnosis, as imaging is for surgical planning only, not diagnosis 2

The American Association of Clinical Endocrinologists recommends obtaining preoperative localization with ultrasound and/or 99mTc-sestamibi SPECT/CT if parathyroidectomy becomes necessary 2
Referring to an experienced parathyroid surgeon is crucial, as subtotal parathyroidectomy or total parathyroidectomy with autotransplantation are effective options, according to the American Thyroid Association 1